Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Targeting RBM39-MEK5 Axis Synergizes with Bortezomib to Inhibit Multiple Myeloma Malignancy

Jia Liu, Zilu Zhang, Wenbin Xu, Ming-Yuan Jia, Chengyu Wu, Yan Hua

Blood (2023) 142 (Supplement 1): 4674.

https://doi.org/10.1182/blood-2023-182900

Published: 2023

Journal Articles

IRF4-BLOC1S5, the First Genomic Fusion Gene Identified in the TEMPI Syndrome

Jia Liu, Zilu Zhang, Wenbin Xu, Qing Yu, Ming-Yuan Jia, Yan Hua

Blood (2023) 142 (Supplement 1): 1923.

https://doi.org/10.1182/blood-2023-184488

Published: 2023

Journal Articles

Clinical Significance of KIR Genotype in Patients with Methotrexate-Associated Lymphoproliferative Disorders

Norina Tanaka, MD PhD, Aya Watanabe, MD, Suguru Honda, MD, Mitsuko Kobayashi, Yan-Hua Wang, MD, Yuki Iizuka, MD, Michiko Ryuzaki, MD, Midori Ishiyama, MD PhD, Akihito Shinohara, MD PhD, Hiroshi Kazama, MD PhD, Shotaro Hagiwara, MD PhD, Kentaro Yoshinaga, MD PhD, Katsunori Ikari, MD PhD, Masayuki Shiseki, MD PhD, Masayoshi Harigai, MD PhD, Junji Tanaka, MD PhD

Blood (2019) 134 (Supplement_1): 5219.

https://doi.org/10.1182/blood-2019-127836

Published: 2019

Journal Articles

Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress

Shotaro Hagiwara, MD PhD, Yan-Hua Wang, MD, Hirohito Kobayashi, MD, Yutaka Kato, MD, Norina Tanaka, MD PhD, Yuki Iizuka, MD, Aya Watanabe, MD, Midori Ishiyama, MD PhD, Akihito Shinohara, MD PhD, Hiroshi Kazama, MD PhD, Kentaro Yoshinaga, MD PhD, Masayuki Shiseki, MD PhD, Hitoshi Kanno, MD PhD, Junji Tanaka, MD PhD

Blood (2019) 134 (Supplement_1): 3133.

https://doi.org/10.1182/blood-2019-127739

Published: 2019

Journal Articles

Research of miR-30b in Cisplatin Resistance of Human NK/T Cell Lymphoma Lines SNK-6 and YTS Cells By Targeting CCL22

Rong Liang, MD PhD, Jian hong Wang, MD, Fang Liu, MD, Xiao hui Duan, MD, Xia Cai Hao, MD, Liang Zhang, MD PhD, Michael Wang, MD, Xiang -xiang Liu, MD, Yan Hua Guo, MD, Zhe Wang, PhD, Hailong Tang, PhD, Ljie Yang, MD

Blood (2018) 132 (Supplement 1): 5302.

https://doi.org/10.1182/blood-2018-99-114405

Published: 2018

Journal Articles

Knockdown of a Wnt Receptor FZD1 reduces MDR1 /P-Glycoprotein Expression in Human Leukemia Cells through the Wnt/β-Catenin Signaling Pathway

Yan-Hua Wang, MD PhD, Toshiko Motoji, MD PhD, Yoichi Imai, MD PhD, Masayuki Shiseki, MD PhD, Kenjiro Mitsuhashi, MD, Ye Ding, MD, Junji Tanaka, MD PhD

Blood (2014) 124 (21): 2225.

https://doi.org/10.1182/blood.V124.21.2225.2225

Published: 2014

Journal Articles

Inhibition of PRAME Expression Causes Cell Cycle Arrest and Apoptosis In Leukemic Cells

Norina Tanaka, MD, Yan-Hua Wang, MD, Masayuki Shiseki, MD, Minoko Takanashi, MD, Toshiko Motoji, MD

Blood (2010) 116 (21): 1695.

https://doi.org/10.1182/blood.V116.21.1695.1695

Published: 2010

Journal Articles

Methylation of the RIZ1 Gene In Myelodysplastic Syndrome and Acute Myeloid Leukemia

Naoki Mori, MD, PhD, Kentaro Yoshinaga, MD, PhD, Mari Ohwashi, MHS, Toshiaki Kondoh, MD, Hanae Shimura, MD, Yan-Hua Wang, MD, PhD, Kenjiro Mitsuhashi, MD, Masayuki Shiseki, MD, PhD, Michiko Okada, PhD, Toshiko Motoji, MD, PhD

Blood (2010) 116 (21): 5112.

https://doi.org/10.1182/blood.V116.21.5112.5112

Published: 2010

Journal Articles

Overexpression of SOX5 by a Novel Chromosome Translocation Involving the IGH Locus In a Follicular Lymphoma without BCL2 Expression

Masayuki Shiseki, MD, PhD, Akihiro Masuda, MD, PhD, Yan-Hua Wang, Kentaro Yoshinaga, MD, PhD, Naoki Mori, MD, PhD, Masanao Teramura, MD, PhD, Toshiko Motoji, MD, PhD

Blood (2010) 116 (21): 4453.

https://doi.org/10.1182/blood.V116.21.4453.4453

Published: 2010

Journal Articles

Inhibition of P-Glycoprotein and Recovery of Drug Sensitivity of Human Acute Leukemic Blast Cells by Multidrug Resistance Gene ( mdr1 ) Antisense Oligonucleotides

Sayuri Motomura, Toshiko Motoji, Minoko Takanashi, Yan-Hua Wang, Hiroko Shiozaki, Isamu Sugawara, Eizou Aikawa, Akihiro Tomida, Takashi Tsuruo, Naotoshi Kanda, Hideaki Mizoguchi

Blood (1998) 91 (9): 3163–3171.

https://doi.org/10.1182/blood.V91.9.3163

Published: 1998

NARROW

Targeting RBM39-MEK5 Axis Synergizes with Bortezomib to Inhibit Multiple Myeloma Malignancy

IRF4-BLOC1S5, the First Genomic Fusion Gene Identified in the TEMPI Syndrome

Clinical Significance of KIR Genotype in Patients with Methotrexate-Associated Lymphoproliferative Disorders

Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress

Research of miR-30b in Cisplatin Resistance of Human NK/T Cell Lymphoma Lines SNK-6 and YTS Cells By Targeting CCL22

Knockdown of a Wnt Receptor FZD1 reduces MDR1 /P-Glycoprotein Expression in Human Leukemia Cells through the Wnt/β-Catenin Signaling Pathway

Inhibition of PRAME Expression Causes Cell Cycle Arrest and Apoptosis In Leukemic Cells

Methylation of the RIZ1 Gene In Myelodysplastic Syndrome and Acute Myeloid Leukemia

Overexpression of SOX5 by a Novel Chromosome Translocation Involving the IGH Locus In a Follicular Lymphoma without BCL2 Expression

Inhibition of P-Glycoprotein and Recovery of Drug Sensitivity of Human Acute Leukemic Blast Cells by Multidrug Resistance Gene ( mdr1 ) Antisense Oligonucleotides

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only